Top

Published in:

01-06-2019 | Peritonitis | Original Article

Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States

Authors: Allison C. Redpath Mahon, Troy Richardson, Alicia M. Neu, Bradley A. Warady, on behalf of the SCOPE Investigators

Published in: Pediatric Nephrology | Issue 6/2019

Abstract

Background

Although peritonitis causes significant morbidity and mortality in children receiving chronic peritoneal dialysis (CPD), little is known about costs associated with treatment.

Methods

We analyzed 246 peritonitis-related hospitalizations in the USA, linked by the Standardized Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) and Pediatric Health Information Systems (PHIS) databases. Multivariable logistic regression was used to assess the relationship between high-cost hospitalizations (at or above the 75th percentile) and patient characteristics. Multivariable modeling was used to assess differences in the service-line specific geometric mean between (1) high- and low-cost (below the 75th percentile) hospitalizations and (2) fungal versus other types of peritonitis. Wage-adjusted hospitalization charges were converted to estimated costs using reported cost-to-charge ratios to estimate the cost of hospitalization.

Results

High-cost hospitalizations were associated with the following: age 3–12 years, Hispanic ethnicity, intensive care unit (ICU) stay, length of stay (LOS), and fungal peritonitis. Whereas absolute standardized cost by service line was significantly different when comparing high- and low-cost hospitalizations, the percentage of total cost by service line was similar in the two groups. Cost per case for fungal peritonitis was higher (p < 0.001) in every service line except pharmacy when compared to other peritonitis cases. The median (IQR) cost of hospitalization for the treatment of peritonitis was $13,655 ($7871, $28434) USD.

Conclusions

Hospitalization-related costs for peritonitis treatment are substantial and arise from a variety of service lines. Fungal peritonitis is associated with high-cost hospitalization.

Available only for authorised users

Fadrowski JJ, Alexander SR, Warady BA (2012) The demographics of dialysis in children pediatric dialysis. In: Warady BA, Schaefer F, Alexander SR (eds) Pediatric Dialysis, 2nd edn. Springer, New York, pp 37–52CrossRef

United States Renal Data System (2017) 2017 USRDS annual data report: volume 2: end-stage renal disease in the United. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda

2011 NAPRTCS Annual Report. North American Pediatric Renal Trials and Collaborative Studies website https://web.emmes.com/study/ped/announce.htm. Accessed February 5, 2018

Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Moller K, von Baum H, Warady BA (2007) Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 72(11):1374–1379CrossRefPubMed

Coyte PC, Young LG, Tipper BL, Mitchell VM, Stoffman PR, Willumsen J, Geary DF (1996) An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients. Am J Kidney Dis 27(4):557–565CrossRefPubMed

Neu AM, Miller MR, Stuart J, Lawlor J, Richardson T, Martz K, Rosenberg C, Newland J, McAfee N, Begin B, Warady BA, SCOPE Collaborative participants (2014) Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol 29(9):1477–1484CrossRefPubMed

Neu AM, Richardson R, Lawlor J, Stuart J, Newland J, McAfee N, Warady BA, SCOPE Collaborative Participants (2016) Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. Kidney 89(6):1346–1354CrossRef

Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yak HK, Schaefer F (2012) Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int 32(Suppl 2):S32–S86CrossRefPubMedPubMedCentral

Shwartz M, Young DW, Siegrist R (2015–2016) The ratio of costs to charges: how good a basis for estimating costs? Inquiry 32(4):476–481

10.

Piraino B, Bernardini J, Jonston JR (1990) Cost analysis of peritoneal catheter infections. Perit Dial Int 10(3):241–242PubMed

11.

Makhija DU, Walton SM, Mora JP, Sanabria RM (2017) Economic impact of a peritoneal dialysis continuous quality improvement program in Colombia. Perit Dial Int 37(2):165–169CrossRefPubMed

12.

Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserrow RP (1988) Accuracy of diagnostic coding for Medicare patients under the prospective payment system. N Engl J Med 318(6):352–355 Erratum in N Eng J Med (1990) 322(21)CrossRefPubMed

13.

Heywood NA, Gill MD, Charlwood N, Brindle R, Kirwan CC, Northwest Research Collaborative (2016) Improving accuracy of clinical coding in surgery: collaboration is key. J Surg Res 204(2):490–495CrossRefPubMed

Title: Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States
Authors: Allison C. Redpath Mahon
Troy Richardson
Alicia M. Neu
Bradley A. Warady
on behalf of the SCOPE Investigators
Publication date: 01-06-2019
Publisher: Springer Berlin Heidelberg
Keywords: Peritonitis
Peritoneal Dialysis
Published in: Pediatric Nephrology / Issue 6/2019
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-018-4183-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2019

Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction

Feeding modality is a barrier to adequate protein provision in children receiving continuous renal replacement therapy (CRRT)

HNF1B nephropathy has a slow-progressive phenotype in childhood—with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry

Renal mass in a 2-year-old girl: Questions

Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia

The population-based prevalence of hypertension and correlates of blood pressure among Australian children